Anatomical Therapeutic Chemical Classification System
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
Palonosetron is a selective high-affinity receptor antagonist of the 5HT3 receptor.
Australia Austria Canada Cyprus Estonia ...
Cyprus Estonia Lithuania Spain
Brazil New Zealand South Africa